Delta Asia International Corporation (TPEX:6762)
165.00
+3.00 (1.85%)
At close: Mar 24, 2026
Delta Asia International Revenue
In the year 2025, Delta Asia International had annual revenue of 694.15M TWD with 19.58% growth. Delta Asia International had revenue of 159.88M in the quarter ending December 31, 2025, a decrease of -9.63%.
Revenue
694.15M
Revenue Growth
+19.58%
P/S Ratio
8.36
Revenue / Employee
3.79M
Employees
183
Market Cap
5.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 694.15M | 113.64M | 19.58% |
| Dec 31, 2024 | 580.51M | 72.49M | 14.27% |
| Dec 31, 2023 | 508.02M | 45.05M | 9.73% |
| Dec 31, 2022 | 462.97M | -68.34M | -12.86% |
| Dec 31, 2021 | 531.32M | -23.00M | -4.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| United Orthopedic | 5.66B |
| Hi-Clearance | 4.28B |
| TaiDoc Technology | 4.20B |
| Wellell | 2.40B |
| InnoCare Optoelectronics | 2.29B |
| Dynamic Medical Technologies | 1.39B |
| WeLeader Biomedical | 1.11B |
| A Plus Biotechnology | 835.89M |